James Hobbs is a senior executive with over thirty years of experience in the healthcare and medical device industry. His business background demonstrates a successful track record starting up and managing companies, commercialization of innovative medical technologies, raising private and public equity capital, creating business development opportunities with strategic corporate partners both in the U.S. as well as internationally, and executing high value mergers and acquisitions.
Mr. Hobbs received his BS degree in physics from Wake Forest University and earned his MBA from the University of North Carolina. He is currently Chairman of the Board at ZyCal Bioceuticals and a principal of Parametrics Medical, LLC, as well as a Managing Partner at Graylyn Associates, Inc.
Over the past several years he has served as an investor, advisor, and board member to several early stage medical device companies, companies as well as founding Johnson and Johnson's Professional Diagnostics Inc. He is also a volunteer and member of the Board of Directors of Community Health Charities of New England and is past Board Chair of CHC of America.
James J. Scaffidi is CEO & President of ZyCal Bioceuticals. James launched ZyCal in 2006, after 20 years of sales, marketing and management experience in various healthcare businesses. James holds a degree in Biochemistry, with 3 years of graduate-level research in enzymology and protein purification. He has published several peer-reviewed clinical studies and trials and is currently completing his doctorate in natural medicine.
Dr. Tripodi holds a PhD in Immunochemistry from Temple University. He has published extensively in the fields of immunochemistry and immunology, and holds several patents, for both drugs and devices. Most of Dr. Tripodi’s industrial career was with Johnson & Johnson for more than 20 years.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.